Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841373 · ClinicalTrials.gov registry record · Phase 1
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
A Phase 1 study of Retinal Ischemia, sponsored by Southern New England Retina Associates.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT00841373: Completed Phase 1 study of Retinal Ischemia, sponsored by Southern New England Retina Associates.
NCT00841373 is a Phase 1 study of Retinal Ischemia that has completed, run by Southern New England Retina Associates. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00841373, a Phase 1 study of Retinal Ischemia, has completed, sponsored by Southern New England Retina Associates.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
The object of the study is to compare treatment of iris/angle neovascularization with panretinal photocoagulation (laser) to treatment with panretinal photocoagulation and an anti-angiogenic drug: ranibizumab.
Conditions Studied
Interventions
- PROCEDURE Panretinal Photocoagulation
- PROCEDURE Panretinal Photocoagulation and intravitreal injection of ranibizumab
Study Locations (1)
Rhode Island
- Southern New England Retina Associates - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
What the finished NCT00841373 record still lists
NCT00841373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Retinal Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Panretinal Photocoagulation is the first listed.
NCT00841373 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00841373 about?
NCT00841373 is a clinical study titled "Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease". The object of the study is to compare treatment of iris/angle neovascularization with panretinal photocoagulation (laser) to treatment with panretinal photocoagulation and an anti-angiogenic drug: ranibizumab.
What is the current status of trial NCT00841373?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2007-07. Estimated completion is 2010-01.
What conditions does trial NCT00841373 study?
This clinical trial studies the following conditions: Retinal Ischemia.
What interventions are being tested in trial NCT00841373?
The interventions under investigation include: Panretinal Photocoagulation (PROCEDURE), Panretinal Photocoagulation and intravitreal injection of ranibizumab (PROCEDURE).
Who is sponsoring clinical trial NCT00841373?
This trial is sponsored by Southern New England Retina Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00841373 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00841373's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia